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Purpose: This study was undertaken to evaluate changes in quality of life and to compare conventional outcomes in
patients undergoing endovascular and open retroperitoneal abdominal aortic aneurysm (AAA) repair.
Methods: Between October 2000 and May 2003, 129 patients underwent elective AAA repair, endovascular repair in 22
patients and open retroperitoneal repair in 107 patients. The Short-Form Health Survey, 12 items (SF-12) was
administered preoperatively and at 3 weeks, 4 months, and 1 year after discharge. Quality of life, hospital and intensive
care unit stay, perioperative complications, discharge disposition, readmission, and hospital cost were statistically
evaluated.
Results: For the total group, significant differences were observed for both Physical Component Summary scores (P <
.001) and Mental Component Summary scores (P .001) between time points. There were no significant differences for
either Component Summary score between open and endovascular procedures for any time period. Number of weeks
required to return to baseline functional status was similar after either open or endovascular repair (7.22 vs 5.47 weeks,
respectively; P  .09). Mean hospital and intensive care unit stay was 4.4 and 1 days, respectively, for open repair versus
1.9 and 0 days, respectively, for endovascular repair (P < .0001). No significant difference between groups was observed
in terms of perioperative complications, discharge disposition, or hospital readmission (P> .54). Mean total hospital cost
for endovascular repair was 1.60 times that for open repair (mean difference, $11,662; P < .0001; 95% confidence
interval, $17,799-$5525).
Conclusions: Hospital stay is significantly shorter after endovascular AAA repair. However, hospital cost is almost twice
that for open retroperitoneal repair. Perioperative complications, discharge disposition, and hospital readmission are not
statistically different between the two groups. Effect on health-related quality of life is similar after either open
retroperitoneal or endovascular AAA repair. (J Vasc Surg 2004;39:797-803.)Abdominal aortic aneurysm (AAA) repair has under-
gone revolutionary change in the last 14 years. Vascular
surgeons have increasingly used endovascular techniques,
and the list of uniquely designed endografts has grown.
Paralleling this experience has been renewed enthusiasm for
retroperitoneal aortic exposure for “open” repair.1-6 This
approach to open repair is associated with fewer complica-
tions, shorter hospital and intensive care unit (ICU) days,
and decreased cost, compared with transperitoneal aortic
exposure.1-6 These divergent methods of AAA repair have
advanced in an era when outcomes of both new and con-
ventional surgical procedures are shadowed by the need to
demonstrate that quality of life (QOL) is positively affected
by the treatment chosen.
Threat of AAA rupture is essentially eliminated with
both open and endovascular repair. However, endografts
are promoted as causing less morbidity, being better toler-
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doi:10.1016/j.jvs.2003.11.037ated, and associated with faster recovery, compared with
“open” AAA repair.7-9 This has led some surgeons and
prospective patients to the notion that QOL is enhanced
with endovascular AAA repair. Yet almost all reports to date
have compared endovascular AAA repair with transperito-
neal open AAA repair. Our experience with retroperitoneal
open AAA repair has been distinctly different from that
recorded in most reports of traditional open AAA repair1;
we observed that our patient outcomes seemed similar
whether the treatment method was retroperitoneal or en-
dovascular.
Therefore we evaluated changes in QOL and other
benchmark outcomes in patients undergoing either endo-
vascular or open AAA repair over a recent two and a half
years. The impetus for this study was threefold: our expe-
rience with retroperitoneal open AAA repair has been
strongly positive; few prospective QOL reports focus on
AAA repair in general; and no prospective QOL reports
compare endovascular with retroperitoneal open AAA re-
pair.9-13
METHODS
Our prospectively managed vascular registry revealed
129 consecutive nonrandomized patients who had under-
gone elective infrarenal AAA repair at Loma Linda Univer-
sity Medical Center between October 2000 and May 2003.
Twenty-two of these patients had undergone endovascular
repair, with bifurcated industry-made devices deployed797
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was performed in 107 patients, with the same preoperative
and postoperative published protocols.1 The open method
was chosen for the following reasons: patient preference
(29 patients; 27%), unfavorable aortic aneurysm neck anat-
omy or excessive angulation (40 patients; 37%), and iliac or
other access vessel problems (38 patients; 36%). Over this
same two and a half years 75 additional aortic aneurysms
were also repaired at the medical center; however, these
were excluded from this study because they were thoraco-
abdominal (n 40), ruptured (n 25), or suprarenal (n
10) aneurysms.
The Short-Form Health Survey, 12 items (SF-12) was
administered preoperatively and at 3 weeks, 4 months, and
1 year after hospital discharge. The SF-12 is a multipurpose
short-form generic measure of health status.14 It was de-
veloped to be a much shorter, yet valid, alternative to the
Short-Form Health Survey, 36 items (SF-36) for use in
surveys of general and specific populations and in longitu-
dinal studies of health outcomes. All of the SF-12 items
come from the SF-36 Health Survey. Thus the SF-12
measures eight concepts commonly represented in widely
used health surveys: physical functioning, role limitations
due to physical health problems, bodily pain, general
health, vitality (energy, fatigue), social functioning, role
limitations due to emotional problems, and mental
health.14 Patients were also queried as to when they
thought they had returned to baseline health status in terms
of weeks from the date of surgery, and whether they would
undergo the same procedure again.
QOL was compared between time points for the total
group, and also compared at the same time points between
the open and endovascular groups. Demographic features,
hospital and ICU stays, perioperative complications, dis-
charge disposition, readmission within 6 weeks of surgery,
and hospital costs (direct, indirect, total) were statistically
compared between the open and endovascular repair
groups. Cost (not charge) data were obtained directly from
our accounting office, and included all direct costs related
Table I. Patient demographic data
Gender (%)
Male
Female
Age (y)
Mean
Range
Nicotine abuse (present or past) (%)
Hypertension (medically treated) (%)
History of MI, CHF, or angina (%)
History of COPD (%)
Elevated cholesterol/lipid (medically treated) (%)
Renal insufficiency (Cr  1.5) (%)
Diabetes (IDDM, NIDDM) (%)
MI, Myocardial infarction; CHF, congestive heart failure; COPD, chronic o
NIDDM, non-insulin-dependent diabetes.to the surgical procedure, in addition to indirect costs of
overhead that were allocated to the treating department.
Direct costs, some of which were based on an hourly rate,
included all labor and supplies related to delivery of the
procedure. Indirect costs included expenses of the admin-
istrative or ancillary cost centers, and expenses such as
utilities, which were allocated on a broad basis, such as
square footage of the providing department. Follow-up was
available for all patients, and was obtained from outpatient
clinical examination and our Health Insurance Portability
and Accountability Act (HIPAA)–compliant vascular reg-
istry.
Statistical analysis Data were exported from our pro-
spectively maintained registry into a statistical software
program (SPSS for Windows, version 10; SPSS, Chicago,
Ill) and retrospectively analyzed. Group comparison and
means testing was with t test and cross-tabulation with 2
analysis. Repeated measures analysis of variance (ANOVA)
was used to determine whether there were any significant
differences between the four time periods for Physical
Component Summary (PCS-12) and Mental Component
Summary (MCS-12) scores. Independent samples t test was
used to determine whether there were any significant dif-
ferences between PCS-12 and MCS-12 scores for open and
endovascular repair at each of the four time periods. P 
.05 was considered statistically significant.
RESULTS
Patient demographic data are given in Table I. Only
mean age was different between the two groups. Mean
hospital and ICU stay was 4.4 and 1 days, respectively, for
open AAA repair versus 1.9 and 0 days, respectively, for
endovascular repair (P  .0001). Ten patients with open
AAA repair (9.3%) and one patient with endovascular repair
(4.5%) had perioperative complications (P  .689). In the
open repair cases complications included nonhemodynami-
cally significant myocardial infarction, respiratory insuffi-
ciency, and ischemic colitis in two patients each, and delir-
ium tremens, retroperitoneal hematoma, atheroembolism,
repair
107)
Endovascular repair
(n  22) P
.25
76 90
24 10
.043
72 77
–89 51–87
73 62 .30
81 62 .09
79 81 1.00
53 34 .15
57 57 1.00
18 10 .16
19 38 .09
tive pulmonary disease; Cr, creatinine; IDDM, insulin-dependent diabetes;Open
(n 
33
bstruc
CS, M
JOURNAL OF VASCULAR SURGERY
Volume 39, Number 4 Ballard et al 799and wound seroma in one patient each. In one of the
endograft cases the procedure was complicated by diffuse
atheroembolism, which resulted in mild ischemic colitis,
transient need for dialysis, and bilateral trash foot. These
related but distinct complications resolved with conserva-
tive treatment. There were no perioperative deaths in either
group. Late deaths occurred in two patients in the open
repair group, 17 and 19 months, respectively, after surgery
(cardiac-related, stroke) and in one patient in the endograft
group, 16 months after surgery (cardiac-related) (P .42).
Discharge disposition was not statistically different be-
tween the groups (P  .58). One patient in the open AAA
repair group was discharged to a skilled nursing facility, and
five patients were discharged to our in-patient rehabilita-
tion unit, with a mean stay of 9 days (range, 5-15 days). The
remainder of the patients were discharged to home. All
patients in the endograft group were discharged to home.
Five patients in the open repair group and one patient in the
endograft group were readmitted to the hospital within 6
weeks of discharge (P  1.00). In the open repair group,
readmissions were because of abdominal pain or nausea,
cardiac dysrhythmia, exacerbation of chronic obstructive
pulmonary disease, diverticulosis, and wound infection, in
one patient each. In the endograft group the single read-
mission was for nonoperative treatment of ischemic colitis,
acute tubular necrosis, and bilateral trash foot. The average
readmission stay was 3.67 days for the total group (range,
2-6 days). Mean patient follow-up was 17.5 months.
Mean PCS-12 and MCS-12 scores were tabulated
when each survey was completed, and are shown in Table
II. Note that both PCS and MCS scores decline at postop-
erative week 3, but return to baseline by 4 months. The
1-year scores are essentially identical to those obtained at 4
months. ANOVA demonstrated significant differences be-
Table II. SF-12 component scores for entire AAA group
Preoperative (n  129)
Postoperative
3 weeks (n  129)
4 months (n  118)
1 year (n  84)
Values represent mean  SD. PCS, Physical Component Summary score; M
Table III. SF-12 component scores: open versus endovasc
Open repair
PCS-12
Preoperative 41.5 (n107)
Postoperative
3 weeks 32.2 (n107)
4 months 42.2 (n 98)
1 year 42.1 (n 72)
PCS, Physical Component Summary score; MCS, Mental Component Sumtween the four periods for PCS-12 scores (F  23.3; P 
.001) and MCS-12 scores (F  8.7; P  .001). Further
analysis showed a significant difference between the mean
PCS-12 and MCS-12 scores at 3 weeks compared with the
three other periods. Table III compares the mean PCS-12
and MCS-12 scores for open and endovascular AAA repair
by time period. Independent samples t test did not demon-
strate significant differences between the groups for
PCS-12 and MCS-12 scores at each of the four periods (all
P values  .05).
Patients were asked to report the number of weeks
before they returned to their baseline health and functional
status. The number of weeks required to return to baseline
functional status was similar after either open or endovas-
cular repair (7.22 vs 5.47 weeks, respectively; P  .09).
Patients were also asked whether they would undergo the
same procedure again, and no significant difference was
noted in their response at any postoperative point. For
example, at 4-month follow-up, four patients in the open
AAA repair group (3.7%) and one patient in the endograft
group (4.5%) reported that they would not elect to un-
dergo the chosen procedure again (P  1.00).
Direct, indirect and total hospital costs, including re-
habilitation and readmission costs, were significantly differ-
ent for each group. Mean direct cost in the endovascular
group was 1.50 times that in the open repair group (mean
difference, $7109; P .009; 95% confidence interval [CI],
$1787-$12,431), and mean indirect cost was twice that in
the open repair group (mean difference, $4552; P .0001;
95% CI, $6118-$2986). Mean total hospital cost in the
endovascular group was 1.60 times that in the open repair
group (mean difference, $11,662; P  .0001; 95% CI,
$17,799-$5,525).
PCS-12 MCS-12
.5  11.0* 49.8  11.0
.7  8.4 46.0  10.3
.8  10.2 52.0  9.2
.0  11.7 51.4  9.0
ental Component Summary score.
repair
Endovascular repair
S-12 PCS-12 MCS-12
.8 41.5 (n22) 49.5
.8 34.9 (n22) 46.8
.4 39.8 (n20) 50.2
.5 41.4 (n12) 51.0
core.41
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41
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MC
49
45
52
51
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This study examined QOL before and after either open
retroperitoneal or endovascular AAA repair. The analysis
demonstrated deterioration in both SF-12 PCS and MCS
scores at postoperative 3 weeks in patients undergoing AAA
repair, regardless of the procedure; however, by 4 months
after surgery all scores had returned to baseline. At 1 year
the QOL scores were essentially the same as those obtained
preoperatively and at 4 months. QOL scores stratified
between endovascular and open repair groups were similar
at all time points.
In addition, the number of weeks required to return to
preoperative functional health status was statistically equiv-
alent after either open retroperitoneal or endovascular AAA
repair. There was also no significant difference noted be-
tween the groups in terms of perioperative complications,
discharge disposition, or hospital readmission. Significant
differences demonstrated between the two groups included
mean patient age, initial hospital stay, and hospital costs.
Endovascular repair was more costly than open repair,
despite a 50% shorter initial hospital stay. However, the
small size of the endovascular group, the potential for
selection bias, the QOL instrument used, the mean age
difference between the groups, and the possibility of a type
II error in statistical analysis temper these findings.
The relatively low number of patients in the endovas-
cular AAA repair group compared with the open repair
group reflects our tertiary referral practice and also our
conservatism. Many patients referred to us for endografts
are not candidates on the basis of anatomic criteria, and
some are reluctant to commit to a rigorous postoperative
imaging program. In our clinical practice many patients
seem to prefer the retroperitoneal approach when both
procedures are well-described in an unbiased fashion based
on our actual experience. There is no doubt that we are
more likely to recommend open surgery for younger pa-
tients and an endograft for patients with a more limited life
expectancy. Herein lies the potential for selection bias in
this study.
The standard version of the SF-12 survey was used
rather than the SF-36, because of its brevity and because
the shorter survey is a valid, alternative to the SF-36 sur-
vey.14 This instrument is representative of the summary
measures of the SF-36 (PCS and MCS), but is less sensitive
for detecting minor differences in the eight different scales
measured with the more extensive SF-36 survey. Therefore
the potential to miss minor differences in either Compo-
nent Summary score is certainly possible. However, this
study was not designed to find minor differences in QOL.
Furthermore, regarding the potential for mean patient
age difference between the groups to affect baseline and
subsequent QOL scores, we did not find this to be the case.
In this study those patients undergoing the endograft pro-
cedure were older, on average, but in similar health, on the
basis of demographic data, compared with the open retro-
peritoneal repair group. Despite the difference in mean age,
QOL data were similar at all measured time points, regard-less of the type of AAA repair. Administration of the SF-12
survey at different time points, such as 1 week or 6 weeks
postoperatively, may have uncovered minor differences be-
tween the groups, but this study was powered only to
discern major intergroup differences. If all demographic
data, including age, were essentially equal between the
groups, it seems reasonable to expect a shorter time for the
endograft group to return to baseline health status, com-
pared with the open repair group. However, the mean age
difference could have biased this comparison toward the
null hypothesis.
Finally, the nonstatistically significant P values associ-
ated with variables such as perioperative complications,
discharge disposition, and hospital readmission, as well as
number of weeks required to return to preoperative func-
tional health status, could represent a type II statistical error
based on the small sample size of the endovascular group.
There are two possible reasons for P  .05: either there is
no difference or there is a difference but the sample size is
not large enough to show it. Data analysis in the future
might demonstrate significant group differences if there are
more patients in the endovascular group.
Nevertheless, life quality and cognitive function after
elective AAA repair have been investigated previously. Per-
kins et al12 demonstrated that overall QOL is improved
after conventional open aortic aneurysm repair, despite an
initial worsening up to 6 weeks postoperatively. Similar to
the present study, QOL was restored to preoperative levels
by 3 months in their study. Magee et al13 showed that, in
contrast to patients with ruptured AAAs, those undergoing
conventional elective AAA repair retain good QOL. Lloyd
et al10 demonstrated that endovascular surgery had a simi-
lar effect on health-related QOL and cognitive function
when compared prospectively with patients undergoing
conventional transperitoneal AAA repair. Finally, Malina et
al11 showed that 3 months after aneurysm surgery patient-
perceived QOL seemed better than before treatment. In
addition, they demonstrated that perceived health-related
QOL was similar whether surgical treatment was endovas-
cular or open.
In contrast to the above studies, Aquino et al9 demon-
strated that patients with endoluminally treated AAAs re-
turned to their baseline status (using the SF-36) twice as
fast as those who underwent surgical repair with transperi-
toneal aortic exposure (4 versus 8 weeks). These authors
concluded that there is an advantage to endovascular ther-
apy over conventional open therapy. Arko et al7 retrospec-
tively concluded that endovascular AAA repair reduced
early and late morbidity, compared with conventional open
repair. This was followed by another report from the same
authors that concluded that perioperative survival was im-
proved after endovascular AAA repair compared with con-
ventional repair, and that recovery was quicker, with a 78%
reduction in total hospital days.8 However, these last two
cited studies were not prospective, and in each of the
above-mentioned studies endovascular AAA repair was
compared with conventional open transperitoneal AAA
repair. Clearly, AAA repair via transperitoneal aortic expo-
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endovascular repair. This can be gleaned simply by noting
that the average hospital stay was 8 days for open repair in
the reports by Arko et al,8 Lloyd et al,10 and Malina et al.11
In contrast, the average hospital stay for patients undergo-
ing open retroperitoneal AAA repair in the present study
was 4.4 days.
Even so, the effect of endovascular AAA repair is signif-
icant. Promotion (commercial and otherwise) of endovas-
cular technology has attracted much attention in the med-
ical and lay press.15-19 The touted features of the
endovascular operation have led to widespread public and
medical perception that the procedure is somehow better
than open AAA repair. Endovascular AAA repair is often
referred to as “minimally invasive” compared with conven-
tional AAA repair, with the added benefits of decreased risk
and faster healing.7,8,15-19 For many treating physicians
and patients the natural extension of this notion is that the
minimally invasive procedure translates into improved
overall health-related QOL. However, the open aortic ex-
posure that endovascular repair has been compared with
has been transperitoneal in most published studies to
date.6-13 In our experience the retroperitoneal approach
has limited the differences between the two groups.
Although the present study has the cited limitations
and includes mostly open repair procedures compared with
endovascular repair procedures, surprisingly similar QOL
was reported at all time periods. All patients returned to
baseline physical and mental status within 4 months of
surgery, whether surgical treatment was endovascular or
open retroperitoneal. Data analysis in the future could
demonstrate significant differences between the groups
with recruitment of more patients for the endovascular
procedure and administration of the QOL survey at differ-
ent time points. However, results from the present study
suggest that the decision to offer endovascular aneurysm
repair should not be based on the expectation that QOL
will be improved.
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Quinones, MD (Los Angeles, Calif). I actually had given the questions to
Jeff, and he answered one of them during the presentation. I am going to do
the opposite of Tim; I may not read what I brought here.I actually had two
copies of the manuscript, but, to Jeff’s credit, they were both identical, so I
would like to congratulate Dr Ballard and his colleagues for bringing
objective criteria to the controversial issue of endovascular versus surgical
repair of abdominal aortic aneurysms. Five years ago at this meeting in
Whistler we presented our results comparing endovascular with retroperito-
neal and transperitoneal aneurysm repair. At that time the cost of the
prosthesis was estimated to be about $5000. We found that the cost of
endovascular repair was equivalent to retroperitoneal repair, but lower than
transperitoneal repair. With an increase in the cost of the device, retroperi-
toneal aortic aneurysm repair has become much more competitive in terms
of cost. We also reported no significant differences in early morbidity and
mortality. The question that remains, however, is how patients feel after
having one or the other procedure, and it is in this regard that the study
presented today by Dr Ballard and his colleagues starts placing in proper
perspective these alternatives in the management of our patients. I share with
them the experience that retroperitoneal abdominal aortic aneurysm repair is
not only well-tolerated, but allows the patient to be discharged home sooner
than with the transperitoneal approach, and this translates into a significant
cost benefit. This does not take into account the cost of surveillance, which
must be added with patients treated with an endovascular graft. Two
prospective trials to date comparing transperitoneal and retroperitoneal
repair have reported no significant difference between the two approaches,
with the exception of return of gastrointestinal tract function. Nevertheless,
one must take into account that these trials were performed when there was
little or no pressure to discharge our patients early. I submit to you that if
these trials were done today we would find a significant difference in hospital
stay favoring the retroperitoneal approach. Dr Ballard and his colleagues
conclude that from a quality of life standpoint and cost, retroperitoneal
repair is competitive and perhaps better than endovascular repair.This con-
clusion must be tempered by analysis of the actual data gathered by the
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number of patients in each group. Only 22 patients of the 129 patients in this
report had an endovascular repair. Thus any small increase in any of the
parameters measured could have a significant effect. Therefore my first
question: Have you performed any power analysis on your data to see if the
small numbers in one of the two groups may have an effect on the validity of
your conclusion? What is the potential for a type II statistical error?There is
also a significant difference in the mean age of the two groups. Patients in the
endovascular group were significantly older, and this could potentially alter
the conclusion reached by the authors, given that older patients received a
less invasive procedure. Therefore equivalency between the quality of life
parameters could be a reflection of an older age group having a smaller
procedure in the endovascular group. This leads to my next questions: How
many patients 80 years or older were in each group? Did you perform a
separate analysis in patients older than 80 years, in whom an endovascular
repair may start showing some of its benefits during the postoperative
period?Finally, the severity of the postoperative complications in both
groups appears different. Whereas patients in the retroperitoneal repair
group had myocardial infarctions, respiratory insufficiency, ischemic colitis,
retroperitoneal hematoma, atheroembolus, and wound complications, the
patients in the endovascular group had a type II endoleak and one athero-
embolism listed as complications. I submit that a type II endoleak, whereas
it is an issue in the endovascular approach, should not be considered a
postoperative complication, as most of them resolve spontaneously, and if
intervention is needed it really becomes part of the treatment package. Thus
my last question: Did you analyze your complications using severity scores to
see if there is a difference in the seriousness of the complications in either
group? If the type II endoleak were not considered a complication, would
there still be no significant difference in morbidity?Once again, I congratu-
late the group from Loma Linda for their excellent presentation, and
encourage them to continue to look at this issue, because it helps place in
perspective for our patients the various alternatives that we now have to
manage abdominal aortic aneurysms. I also wish to thank the Society for the
opportunity to discuss this excellent paper.Dr Jeffrey L. Ballard. Bill, thank
you for those questions.We did not perform a power analysis, and obviously
the case number discrepancy is the weakest link of the study. There is
potential for a type II statistical error. However, data collection continues,
and our endograft cases are increasing in frequency. We plan to review these
data again in a few years.We did not perform a separate analysis of patients
over age 80. My observation over the years with these AAA patients is that,
basically, an operation is an operation. One may have predicted that an older
patient would recover quicker after an endograft repair, but that does not
appear to be the case based on the QOL data.We did not use severity scores
during data analysis. The complication numbers are small for both groups,
and removing the type II endoleak may have changed the &Chi2 analysis.Dr
Christopher Zarins (Stanford, Calif). I very much enjoyed this paper.
My question is, you have found that there is no difference between the
recovery and the outcome of the retroperitoneal repair and the endovas-
cular repair, and that it is cheaper, and then you conclude that you hope
that the endovascular group continues to enlarge and that you expect
that this endovascular group will continue to enlarge. How do you
reconcile this, and how do you now approach your patients when you talk
to them? Do you recommend that they have endovascular repair, which
you are hoping for, yet your data do not support that?Dr Ballard. I’m
not actually hoping for more endograft cases, but we do tend to recom-
mend endografts for older patients. We generally don’t push the enve-
lope with endografts, because we are pleased with our results after open
retroperitoneal AAA repair. Patients are allowed to decide which treat-
ment they prefer based on our objective data. These results have been
helpful to use in the clinic, and these data assist us in answering the
question about recovery after surgery. I suspect that our endograft
volume will continue to increase, as more versatile grafts become avail-
able to use.Dr George Andros (North Hollywood, Calif). Your data are,
of course, at odds with most workers’. The Europeans have clearly
shown, as recently as just last month, that Victor Bernhard and I heard in
Dublin, on a very large well-powered study that showed that at 3 months
most patients prefer an endograft to an open procedure, and the numbers
are clearly statistically significant. What they also showed was that at 6
months there was a clear crossover and that patients preferred open
procedures. This has been shown repeatedly in Europe. The thing that ismost interesting is that at 2 years both of them showed worse quality of
life outcomes than before, so neither group liked it very much. Keep in
mind that they were using an SF-36 and dedicated quality—of-life
analysis for aneurysm repair, not just the SF-12. I think that there are
many issues of what you like.Who administered the study, and was there
any bias of the person, encouraging along one line of preference? The
question is, do you think we are going to see this kind of work when we
have more carotid stenting done?Dr Ballard. We administered the survey
to our patients when they were in clinic, and we did not sit with them
while they answered the questions. The SF-12 survey is really easy to fill
out, so it was returned to us before the patient left the clinic. It is
probably not a bad idea to do quality-of-life surveys with stenting or any
other procedure we do. One learns a lot about
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issues with patients that change quality of life, and these may have
nothing to do with the operation. The trouble is in trying to figure out
how to factor those issues into the quality-of-life equation.Dr Stephen
Murray (Spokane, Wash). Jeff, I was interested in the number of patients
you had in what you refer to as inpatient rehab facility. Dr Ballard. When
the patients go to our rehab unit they are discharged from us and
readmitted to rehab. The length of stay data include those days on rehab.
Only a handful of patients were discharged from our service to rehab.PREVIEW UPCOMING ARTICLES ON THE WEB
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